Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Omic Approaches to Characterize the Functional and Phenotypic Consequences of Rare Structural Genomic Variants in Neurodevelopmental Disabilities and Congenital Anomalies

NCT06337396 is registered in ClinicalTrials.gov with IRCCS Eugenio Medea as lead sponsor.

NCT NCT06337396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06337396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Omic Approaches to Characterize the Functional and Phenotypic Consequences of Rare Structural Genomic Variants in Neurodevelopmental Disabilities and Congenital Anomalies
Lead sponsor
IRCCS Eugenio Medea
Phase
Not applicable
Overall status
Completed
Start date
May 5, 2021
Completion date
December 31, 2023
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurodevelopmental disorders